{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:39:05Z","timestamp":1790102345782,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Senior Research Fellowship (SRF)","award":["BIC\/11(16)\/2014"],"award-info":[{"award-number":["BIC\/11(16)\/2014"]}]},{"name":"IRIS ID","award":["2014\u201323020"],"award-info":[{"award-number":["2014\u201323020"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jmgm.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T04:27:26Z","timestamp":1528259246000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An in silico assessment"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-3108","authenticated-orcid":false,"given":"Sarfaraj","family":"Niazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudan","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Sonawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-9676","authenticated-orcid":false,"given":"Javed H.","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2018.06.003_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2018.06.003_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","author":"Jorissen","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1097-2765(03)00350-2","article-title":"An open-and-shut Case? Recent insights into the activation of EGF\/ErbB receptors","volume":"12","author":"Burgess","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmgm.2018.06.003_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/bcr1633","article-title":"HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks","volume":"9","author":"Landgraf","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/annonc\/12.suppl_1.S3","article-title":"The basic biology of HER2","volume":"12","author":"Rubin","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jmgm.2018.06.003_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000055396","article-title":"Biology of HER2 and its importance in breast cancer","volume":"61","author":"Yarden","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.jmgm.2018.06.003_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jmgm.2018.06.003_bib8","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1038\/sj.onc.1203973","article-title":"Molecular mechanisms underlying ErbB2\/HER2 action in breast cancer","volume":"19","author":"Harari","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.jmgm.2018.06.003_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2018.06.003_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-1119(94)00459-6","article-title":"HER-2\/neu-targeting gene therapy\u2013a review","volume":"159","author":"Hung","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.jmgm.2018.06.003_bib11","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1038\/sj.onc.1205794","article-title":"Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR\/erbB2 and downstream Erk1\/2 and AKT pathways","volume":"21","author":"Xia","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jmgm.2018.06.003_bib12","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","article-title":"A\u00a0unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells","volume":"64","author":"Wood","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib13","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.1073\/pnas.95.20.12022","article-title":"Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor","volume":"95","author":"Fry","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2018.06.003_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/jm040159c","article-title":"Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity","volume":"48","author":"Tsou","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.06.003_bib15","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-04-3700","article-title":"Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model","volume":"65","author":"Yokoi","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6604108","article-title":"A\u00a0phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours","volume":"98","author":"Eskens","year":"2008","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.jmgm.2018.06.003_bib17","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1158\/1078-0432.CCR-06-0642","article-title":"Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1\/HER2 homodimer and heterodimer signaling","volume":"12","author":"Wong","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib18","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","article-title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non\u2013small cell lung cancer","volume":"290","author":"Kris","year":"2003","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jmgm.2018.06.003_bib19","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1158\/0008-5472.CAN-06-3559","article-title":"Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor","volume":"67","author":"Jani","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1535-6108(04)00083-2","article-title":"Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex","volume":"5","author":"Franklin","year":"2004","journal-title":"Canc. Cell"},{"key":"10.1016\/j.jmgm.2018.06.003_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature01392","article-title":"Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab","volume":"421","author":"Cho","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jmgm.2018.06.003_bib22","doi-asserted-by":"crossref","first-page":"31676","DOI":"10.1074\/jbc.M111.235184","article-title":"Structural insights into the down-regulation of overexpressed p185(her2\/neu) protein of transformed cells by the antibody chA21","volume":"286","author":"Zhou","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.06.003_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jmb.2010.07.027","article-title":"Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine","volume":"402","author":"Fisher","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jmgm.2018.06.003_bib24","doi-asserted-by":"crossref","first-page":"15039","DOI":"10.1073\/pnas.1005025107","article-title":"Structural basis for high-affinity HER2 receptor binding by an engineered protein","volume":"107","author":"Eigenbrot","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2018.06.003_bib25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.str.2013.08.020","article-title":"Structural basis for eliciting a cytotoxic effect in her2-overexpressing cancer cells via binding to the extracellular domain of HER2","volume":"21","author":"Jost","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2018.06.003_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1039\/C4AN01665C","article-title":"In\u00a0vitro HER2 protein-induced affinity dissociation of carbon nanotube-wrapped anti-HER2 aptamers for HER2 protein detection","volume":"140","author":"Niazi","year":"2015","journal-title":"Analyst (Cambridge, U.K.)"},{"key":"10.1016\/j.jmgm.2018.06.003_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/nar\/gkm008","article-title":"DISPLAR: an accurate method for predicting DNA-binding sites on protein surfaces","volume":"35","author":"Tjong","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib28","doi-asserted-by":"crossref","first-page":"W417","DOI":"10.1093\/nar\/gkq396","article-title":"DNABINDPROT: fluctuation-based predictor of DNA-binding residues within a network of interacting residues","volume":"38","author":"Ozbek","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib29","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2018.06.003_bib30","doi-asserted-by":"crossref","first-page":"W665","DOI":"10.1093\/nar\/gkh381","article-title":"PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations","volume":"32","author":"Dolinsky","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib31","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1093\/nar\/gkq222","article-title":"Pushing the limits of what is achievable in protein\u2013DNA docking: benchmarking HADDOCK's performance","volume":"38","author":"van Dijk","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib32","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/nar\/gkl412","article-title":"Information-driven protein-DNA docking using HADDOCK: it is a matter of flexibility","volume":"34","author":"van Dijk","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2018.06.003_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4:\u2009 algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2018.06.003_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2018.06.003_bib35","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.06.003_bib36","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.06.003_bib37","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2018.06.003_bib38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/00268978300102851","article-title":"Constant pressure molecular dynamics for molecular systems","volume":"50","author":"Nos\u00e9","year":"1983","journal-title":"Mol. Phys."},{"key":"10.1016\/j.jmgm.2018.06.003_bib39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1521-3773(19990115)38:1\/2<236::AID-ANIE236>3.0.CO;2-M","article-title":"Peptide folding: when simulation meets experiment","volume":"38","author":"Daura","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jmgm.2018.06.003_bib40","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1039\/C5MD00319A","article-title":"Rational design of promiscuous binding modulators of p53 inducing E3(Ub)-ligases (Mdm2 and Pirh2) as anticancer agents: an in silico approach","volume":"6","author":"Niazi","year":"2015","journal-title":"Medchemcomm"},{"key":"10.1016\/j.jmgm.2018.06.003_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.06.003_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.str.2012.10.015","article-title":"Nonspecific recognition is achieved in Pot1pC through the use of multiple binding modes","volume":"21","author":"Dickey","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.jmgm.2018.06.003_bib43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/ed500195d","article-title":"Using free computational resources to illustrate the drug design process in an undergraduate medicinal chemistry course","volume":"92","author":"Rodrigues","year":"2015","journal-title":"J.\u00a0Chem. Educ."},{"key":"10.1016\/j.jmgm.2018.06.003_bib44","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1021\/acs.analchem.6b01635","article-title":"Aptamer affinity maturation by resampling and microarray selection","volume":"88","author":"Kinghorn","year":"2016","journal-title":"Anal. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326318303127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326318303127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:58:39Z","timestamp":1761080319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326318303127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":44,"alternative-id":["S1093326318303127"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.06.003","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An in silico assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}